Phillip Thomas
Chairman of the Board of Directors
Phillip C. Thomas, President and Chief Executive Officer at Implant Sciences Corporation (AMEX:IMX), has held senior leadership positions in several public and private high technology companies. Prior to joining Implant Sciences, he served for eight years as CEO of DOBI Medical Systems. Early in his career, he served as Founder and CEO of a drug delivery company successfully sold to Baxter Healthcare and as President of Mitek Systems, Inc. a NASDAQ high tech company specializing in high security data products sold to the federal government and government contractor community. Previously, he was Director, Federal Systems Division at Data General, Inc. and built a $120MM+ product line of high security products at Wang Laboratories during a five year period.

Prior to embarking on his business career, he served with distinction for eight years as a decorated U.S. Naval Intelligence Officer. Mr. Thomas received his undergraduate degree from Brigham Young University and has completed executive development courses at the Harvard and Stanford Business Schools.

David B. Eisenhaure
Director
David B. Eisenhaure has served on our board of directors since November 2002. He has been the President, Chief Executive Officer and Chairman of the Board of SatCon Technology Corporation since 1985. From 1974 until 1985, Mr. Eisenhaure was associated with the Charles Stark Draper Laboratory, Incorporated and with its predecessor, the Massachusetts Institute of Technology's Instrumentation Laboratory, from 1967 to 1974. Mr. Eisenhaure also holds an academic position at M.I.T., as a lecturer in the Department of Mechanical Engineering. Mr. Eisenhaure serves on the board of directors of Mechanical Technology Incorporated. He holds a S.B., S.M. and an Engineer's Degree in Mechanical Engineering from MIT. Mr. Eisenhaure is a member of Implant Sciences’ Compensation and Nominating Committees.

Michael Szycher Ph.D.
Director
Michael Szycher, Ph.D. is the former Chairman and Chief Executive Officer of CardioTech International, Inc. a manufacturer of medical products based on specialized polyurethanes. He holds a Ph.D. from Boston University School of Medicine, and an MBA from Suffolk University.

Dr. Szycher is a recognized international authority on polyurethanes and blood compatible polymers, the author over ninety research articles and a pivotal force in the creation of the Medical Plastics Division of the SPE. He is the Editor of six books, Szycher’s Handbook of Polyurethanes, "Biocompatible Polymers, Metals and Composites;" "Synthetic Biomedical Polymers;" "Blood Compatible Materials and Devices: Perspectives Towards the 21st Century;" High Performance Biomaterials: A Comprehensive Guide to Medical/Pharmaceutical Applications;" "Szycher's Dictionary of Biomaterials and Medical Devices.", "Szycher's Dictionary of Medical Devices" and Szycher’s Handbook of Polyurethanes. He is also Editor-In-Chief of the quarterly Journal of Biomaterials Applications. Dr. Szycher serves as the Chairman of the Nominating Committee and is a member of the Audit Committee.

Michael Turmelle
Director
Michael Turmelle was confirmed as a director of the Company in December 2005. He is currently Chief Financial Officer of Premium Power Corporation, a venture capital backed large format electrical energy storage company.  Prior to Premium Power, Mr. Turmelle held several management positions with SatCon Technology Corporation, including a director, Vice President, Chief Financial Officer and Treasurer, Chief Operating Officer and President of SatCon Power Systems. Prior to SatCon he worked for HADCO Corporation in various financial and operating assignments. Mr. Turmelle graduated from the General Electric Financial Management Training program (FMP) in 1984. He holds a B.A. degree in Economics from Amherst College. Mr. Turmelle serves as the Chairman of Implant Sciences’ Compensation Committee and is a member of both the Company’s Audit and Nominating Committees.

Joseph E. Levangie
Director
Joseph E. Levangie was elected to the Company’s Board of Directors in December 2007. He has been CEO of JEL & Associates, a business advisory firm, since 1981. He has extensive experience in aiding small-cap public companies with their financial and strategic growth challenges. Previously, from 1969-1978, Mr. Levangie was Director of Planning and Marketing Services for Avco (now Textron) Systems Division, a major defense contractor. Since 1983, he has helped several companies become publicly-traded; including Spire Corporation, American Power Conversion Corporation and Palomar Medical Technology, Inc. Mr. Levangie holds a S.B. degree in Chemical Engineering from MIT and an MBA degree from the Harvard Graduate School of Business Administration. He serves as Chairman of the Company’s Audit Committee and is a member of both the Nominating and Compensation Committees.